SPONSOR
European Institute of Oncology
Total Trials
11
Recruiting
11
Phases
Phase 2
Conditions studied: Colorectal CancerALNDSentinel Lymph Node Biopsy (SLNB)Targeted Axillary Dissection (TAD)Neuroendocrine Carcinoma of LungNeuroendocrine Carcinoma of ThymusPapillary Thyroid MicrocarcinomaBreast CancerCancerBone Neoplasms
European Institute of Oncology is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Colorectal Cancer, ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD).
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — European Institute of Oncology
How many clinical trials has European Institute of Oncology sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by European Institute of Oncology, of which 11 are actively recruiting participants. These trials cover conditions including Colorectal Cancer, ALND, Sentinel Lymph Node Biopsy (SLNB). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does European Institute of Oncology research focus on?
European Institute of Oncology clinical trials span Colorectal Cancer, ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD), Neuroendocrine Carcinoma of Lung, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a European Institute of Oncology clinical trial?
To participate in a European Institute of Oncology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all European Institute of Oncology trials with current recruitment status updated daily.
Clinical Trials by European Institute of Oncology
NCT06331988
Recruiting
Microbiome, Immune-system and Tumor Interaction in Colorectal Cancer
Colorectal Cancer
NCT07278726
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
ALND
NCT07429851
Recruiting
CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
Neuroendocrine Carcinoma of Lung
NCT06333587
Recruiting
Minimally Invasive Treatments of the Thyroid
Papillary Thyroid Microcarcinoma
NCT07395336 Phase 2
Recruiting
Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE)
Breast Cancer
NCT07671846
Recruiting
Patient Anxiety During Magnetic Resonance Imaging
Cancer
NCT06300125
Recruiting
Percutaneous Cryoablation of Low-risk Early Breast Cancer
Breast Cancer
NCT06335251
Recruiting
Radiotherapy Treatments for Neoplasms of the Limbs
Bone Neoplasms
NCT06610565
Recruiting
Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer
Breast Cancer
NCT06762496
Recruiting
A New Tool to Promote Patient's Engagement in Their Healthcare Process
Breast Carcinoma
NCT06785077
Recruiting
Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
Leukemia, Myeloid, Acute
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology